InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Aurinia Pharmaceuticals Inc.

AUPH Clue Score77
Alberta, Canada Fiscal year ends December CIK 0001600620
$16.65 +2.65% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $16.65 −18.70% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue0.2Operating income−25.0Net income−23.3Fiscal year 2017Revenue0.4 +141.6%Operating income−46.9Net income−70.8Fiscal year 2018Revenue0.5 +10.8%Operating income−55.2Net income−53.1Fiscal year 2019Revenue0.3 −31.3%Operating income−90.9Net income−88.4EPS, diluted−0.95Fiscal year 2020Revenue50.1 +15,660.4%Operating income−104.3Net income−102.7EPS, diluted−0.87Fiscal year 2021Revenue45.6 −9.0%Operating income−180.7Net income−181.0EPS, diluted−1.40Fiscal year 2022Revenue134.0 +193.9%Operating income−111.5Net income−108.2EPS, diluted−0.76Fiscal year 2023Revenue175.5 +31.0%Operating income−91.7Net income−78.0EPS, diluted−0.54Fiscal year 2024Revenue235.1 +34.0%Operating income−4.7Net income5.8EPS, diluted0.04Fiscal year 2025Revenue283.1 +20.4%Operating income104.9Net income287.2 +4,893.1%EPS, diluted2.07 +5,075.0%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 0.2 0.4 0.5 0.3 50.1 45.6 134.0 175.5 235.1 283.1
Growth +141.6% +10.8% −31.3% +15,660.4% −9.0% +193.9% +31.0% +34.0% +20.4%
Operating income −25.0 −46.9 −55.2 −90.9 −104.3 −180.7 −111.5 −91.7 −4.7 104.9
Net income −23.3 −70.8 −53.1 −88.4 −102.7 −181.0 −108.2 −78.0 5.8 287.2
Growth +4,893.1%
EPS, diluted n/a n/a n/a −0.95 −0.87 −1.40 −0.76 −0.54 0.04 2.07
Growth +5,075.0%

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2016Operating margin−14,466.5%Net margin−13,465.3%Free cash flow margin−10,825.4%Fiscal year 2017Operating margin−11,212.4%Net margin−16,935.9%Free cash flow margin−9,855.0%Fiscal year 2018Operating margin−11,930.9%Net margin−11,464.1%Free cash flow margin−11,153.6%Fiscal year 2019Operating margin−28,598.4%Net margin−27,794.0%Free cash flow margin−20,022.6%Fiscal year 2020Operating margin−208.1%Net margin−204.9%Fiscal year 2021Operating margin−396.3%Net margin−396.8%Fiscal year 2022Operating margin−83.2%Net margin−80.7%Fiscal year 2023Operating margin−52.2%Net margin−44.5%Fiscal year 2024Operating margin−2.0%Net margin2.4%Fiscal year 2025Operating margin37.1%Net margin101.5%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin −14,466.5% −11,212.4% −11,930.9% −28,598.4% −208.1% −396.3% −83.2% −52.2% −2.0% 37.1%
Net margin −13,465.3% −16,935.9% −11,464.1% −27,794.0% −204.9% −396.8% −80.7% −44.5% 2.4% 101.5%
Free cash flow margin −10,825.4% −9,855.0% −11,153.6% −20,022.6% n/a n/a n/a n/a n/a n/a

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow−18.7Capital expenditure−0.0Free cash flow−18.7Fiscal year 2017Operating cash flow−41.2Capital expenditure−0.0Free cash flow−41.2Fiscal year 2018Operating cash flow−51.6Capital expenditure−0.0Free cash flow−51.6Fiscal year 2019Operating cash flow−63.6Capital expenditure−0.1Free cash flow−63.7Fiscal year 2020Operating cash flow−69.9Fiscal year 2021Operating cash flow−157.7Fiscal year 2022Operating cash flow−79.5Buybacks0.0Fiscal year 2023Operating cash flow−33.5Buybacks0.0Fiscal year 2024Operating cash flow44.4Buybacks−40.2Fiscal year 2025Operating cash flow135.7Buybacks−98.2
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −18.7 −41.2 −51.6 −63.6 −69.9 −157.7 −79.5 −33.5 44.4 135.7
Capital expenditure −0.0 −0.0 −0.0 −0.1 n/a n/a n/a n/a n/a n/a
Free cash flow −18.7 −41.2 −51.6 −63.7 n/a n/a n/a n/a n/a n/a
Growth
Buybacks n/a n/a n/a n/a n/a n/a 0.0 0.0 −40.2 −98.2

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2016Cash39.6Shareholders’ equity36.0Fiscal year 2017Cash165.6Shareholders’ equity177.9Fiscal year 2018Cash118.0Shareholders’ equity135.7Fiscal year 2019Cash306.0Shareholders’ equity298.6Fiscal year 2020Cash272.4Shareholders’ equity407.8Fiscal year 2021Cash231.6Shareholders’ equity479.1Fiscal year 2022Cash94.1Shareholders’ equity405.4Fiscal year 2023Cash48.8Shareholders’ equity378.0Fiscal year 2024Cash83.4Shareholders’ equity377.5Fiscal year 2025Cash80.2Shareholders’ equity581.3
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 39.6 165.6 118.0 306.0 272.4 231.6 94.1 48.8 83.4 80.2
Shareholders’ equity 36.0 177.9 135.7 298.6 407.8 479.1 405.4 378.0 377.5 581.3

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Cash flow

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Operations
−18.7 −41.2 −51.6 −63.6 −69.9 −157.7 −79.5 −33.5 44.4 135.7
Growth +205.6%
n/a n/a n/a n/a 1.4 2.8 2.7 11.6 19.4 19.4
Investment
−0.0 −0.0 −0.0 −0.1 n/a n/a n/a n/a n/a n/a
calc −18.7 −41.2 −51.6 −63.7 n/a n/a n/a n/a n/a n/a
Growth
10.0 −8.0 −0.1 7.8 −158.2 −103.9 −60.6 −6.7 39.3 −32.8
Financing
42.6 175.2 4.0 243.9 194.4 221.1 2.4 −5.1 −49.1 −106.1
n/a n/a n/a n/a n/a n/a 0.0 0.0 −40.2 −98.2

Lines marked calc are worked out here from filed figures; point at one for how. Capital expenditure, dividends and buybacks are shown as money out, so negative.